Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Queensland, Australia.
Centre for Children's Health Research, Queensland University of Technology, Brisbane, Queensland, Australia.
Pediatr Pulmonol. 2020 Sep;55(9):2444-2451. doi: 10.1002/ppul.24924. Epub 2020 Jul 6.
INTRODUCTION/AIM: A validated tool for scoring bronchitis during flexible bronchoscopy (FB) is potentially useful for clinical practice and research. We aimed to develop a bronchoscopically defined bronchitis scoring system in children (BScore) based on our pilot study.
Children undergoing FB were prospectively enrolled. Their FB was digitally recorded and assessed (two clinicians blinded to each other and clinical history) for six features: secretion amount (six-point scale), secretion color (BronkoTest, 0-8), mucosal oedema (0-3), ridging (0-3), erythema (0-3), and pallor (0-3) based on pre-determined criteria. We correlated (Spearman's rho) each feature with bronchoalveolar lavage (BAL) neutrophil percentage (neutrophil%). BScore was then derived using models with combinations of the six features that best related to airway BAL neutrophil%. The various models of BScore were plotted against BAL neutrophil% using receiver operating characteristic (ROC) curves.
We analyzed 142 out of 150 children enrolled. Eight children were excluded for unavailability of BAL cytology or FB recordings. Chronic/recurrent cough was the commonest indication for FB (75%). The median age was 3 years (IQR, 1.5-5.3 years). Secretion amount (r = 0.42) and color (r = 0.46), mucosal oedema (r = 0.42), and erythema (r = 0.30) significantly correlated with BAL neutrophil%, P < .0001. The highest area under ROC (aROC) was obtained by the addition of the scores of all features excluding pallor (aROC = 0.84; 95% CI, 0.76-0.90) with airway neutrophilia (defined as BAL neutrophil% of >10%).
This prospective study has developed the first validated bronchitis scoring tool in children based on bronchoscopic visual inspection of airways. Further validation in other cohorts is however required.
简介/目的:用于在纤维支气管镜检查(FB)期间对支气管炎进行评分的验证工具对于临床实践和研究可能很有用。我们旨在根据我们的初步研究制定一种基于儿童纤维支气管镜的支气管炎评分系统(BScore)。
前瞻性地招募接受 FB 的儿童。他们的 FB 被数字化记录并进行评估(两位临床医生彼此之间以及临床病史均为盲法),评估六个特征:分泌物量(六点量表)、分泌物颜色(BronkoTest,0-8)、黏膜水肿(0-3)、脊状隆起(0-3)、红斑(0-3)和苍白(0-3),基于预定的标准。我们将每个特征与支气管肺泡灌洗(BAL)中性粒细胞百分比(neutrophil%)进行相关性分析(Spearman 的 rho)。然后,根据与气道 BAL 中性粒细胞最相关的六个特征的组合,使用模型推导 BScore。使用接收者操作特征(ROC)曲线将各种 BScore 模型与 BAL 中性粒细胞%进行比较。
我们分析了 150 名入组儿童中的 142 名。8 名儿童因 BAL 细胞学或 FB 记录不可用而被排除。慢性/复发性咳嗽是 FB 最常见的指征(75%)。中位年龄为 3 岁(IQR,1.5-5.3 岁)。分泌物量(r = 0.42)和颜色(r = 0.46)、黏膜水肿(r = 0.42)和红斑(r = 0.30)与 BAL 中性粒细胞显著相关,P < 0.0001。排除苍白评分后,所有特征评分之和的 AUC 值最高(aROC = 0.84;95%CI,0.76-0.90),气道中性粒细胞增多(定义为 BAL 中性粒细胞%>10%)(aROC = 0.84;95%CI,0.76-0.90)。
这项前瞻性研究基于气道纤维支气管镜检查,制定了第一个针对儿童的验证性支气管炎评分工具。然而,需要在其他队列中进一步验证。